Published in Am J Hum Genet on November 01, 1992
Identification of common cystic fibrosis mutations in African-Americans with cystic fibrosis increases the detection rate to 75%. Am J Hum Genet (1997) 1.84
Precise genetic mapping and haplotype analysis of the familial dysautonomia gene on human chromosome 9q31. Am J Hum Genet (1999) 1.30
A novel donor splice site in intron 11 of the CFTR gene, created by mutation 1811+1.6kbA-->G, produces a new exon: high frequency in Spanish cystic fibrosis chromosomes and association with severe phenotype. Am J Hum Genet (1995) 1.29
Cystic fibrosis genotypes and views on screening are both heterogeneous and population related. Am J Hum Genet (1992) 1.17
The frequency of the C854 mutation in the aspartoacylase gene in Ashkenazi Jews in Israel. Am J Hum Genet (1994) 1.04
Identification of the M1101K mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene and complete detection of cystic fibrosis mutations in the Hutterite population. Am J Hum Genet (1993) 0.97
Assessing the Disease-Liability of Mutations in CFTR. Cold Spring Harb Perspect Med (2012) 0.96
CFTR haplotype analysis reveals genetic heterogeneity in the etiology of congenital bilateral aplasia of the vas deferens. Am J Hum Genet (1995) 0.95
Cystic fibrosis carrier screening: comparability of data and uniformity of testing. Am J Hum Genet (1994) 0.93
Molecular analysis using DHPLC of cystic fibrosis: increase of the mutation detection rate among the affected population in Central Italy. BMC Med Genet (2004) 0.85
Multiplex ligation-dependent probe amplification identification of whole exon and single nucleotide deletions in the CFTR gene of Hispanic individuals with cystic fibrosis. J Mol Diagn (2008) 0.84
Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis. World J Gastroenterol (2015) 0.79
Cystic fibrosis: current therapeutic targets and future approaches. J Transl Med (2017) 0.75
Cystic fibrosis newborn screening programs: implications of the CFTR variant spectrum in nonwhite patients. Genet Med (2016) 0.75
CFTR Gene Mutations and Asthma in Indian Children: A Case-Control Study. Indian J Clin Biochem (2013) 0.75
Nationwide genetic analysis for molecularly unresolved cystic fibrosis patients in a multiethnic society: implications for preconception carrier screening. Mol Genet Genomic Med (2017) 0.75
A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res (1988) 77.80
Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science (1989) 40.22
Identification of the cystic fibrosis gene: genetic analysis. Science (1989) 33.61
Identification of the cystic fibrosis gene: chromosome walking and jumping. Science (1989) 21.46
A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator protein. Nature (1990) 5.42
Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene. Proc Natl Acad Sci U S A (1990) 4.74
Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis. N Engl J Med (1990) 4.60
Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics (1991) 4.27
Identification of mutations in exons 1 through 8 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics (1991) 2.07
Three point mutations in the CFTR gene in French cystic fibrosis patients: identification by denaturing gradient gel electrophoresis. Hum Genet (1990) 2.05
Methods for analysis of multiple cystic fibrosis mutations. Hum Genet (1991) 1.88
Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease. Am J Hum Genet (1992) 1.85
A mutation in the second nucleotide binding fold of the cystic fibrosis gene. Am J Hum Genet (1991) 1.62
Cystic fibrosis deletion mutation detected by PCR-mediated site-directed mutagenesis. Clin Chem (1990) 1.56
Analysis of 14 cystic fibrosis mutations in five south European populations. Hum Genet (1991) 1.40
Carrier screening for cystic fibrosis. Am J Hum Genet (1990) 1.33
Analysis of four diverse population groups indicates that a subset of cystic fibrosis mutations occur in common among Caucasians. Am J Hum Genet (1992) 1.17
Cystic fibrosis mutations in French Canadians: three CFTR mutations are relatively frequent in a Quebec population with an elevated incidence of cystic fibrosis. Am J Med Genet (1992) 1.15
Detecting multiple cystic fibrosis mutations by polymerase chain reaction-mediated site-directed mutagenesis. Clin Chem (1991) 1.07
Cystic fibrosis. Complementary endeavours. Nature (1990) 1.06
Biochemical and molecular genetics of cystic fibrosis. Adv Hum Genet (1991) 1.04
Screening for non-delta F508 mutations in five exons of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in Italy. Am J Hum Genet (1991) 1.00
The frequency of the delta F508 mutation on cystic fibrosis chromosomes in Israeli families: correlation to CF haplotypes in Jewish communities and Arabs. Hum Genet (1990) 0.85
Cystic fibrosis mutations delta F508 and G542X in Jewish patients. J Med Genet (1992) 0.84
Cystic fibrosis in Israel: clinical and genetic aspects. Isr J Med Sci (1978) 0.79
Nine mutations in the cystic fibrosis (CF) gene account for 80% of the CF chromosomes in French patients. Clin Genet (1991) 0.78
Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature (1991) 11.44
Vascular endothelial growth factor (VEGF) and its receptors. FASEB J (1999) 10.09
The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr (1998) 5.08
The skipping of constitutive exons in vivo induced by nonsense mutations. Science (1993) 4.41
Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med (2001) 3.72
CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP. Cell (1995) 3.46
Single-tube multiplex-PCR screen for common deletional determinants of alpha-thalassemia. Blood (2000) 3.36
Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet (1993) 3.22
Rehabilitation of hypoxemic patients with COPD at low altitude at the Dead Sea, the lowest place on earth. Chest (1998) 2.80
Microscopic satellitosis in patients with primary cutaneous melanoma: implications for nodal basin staging. Ann Surg Oncol (2009) 2.67
Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros (2008) 2.56
Isodisomy of chromosome 7 in a patient with cystic fibrosis: could uniparental disomy be common in humans? Am J Hum Genet (1989) 2.43
In vivo model of adeno-associated virus vector persistence and rescue. J Virol (1996) 2.41
The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Hum Genet (1997) 2.28
Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 [corrected]. J Biol Chem (2000) 2.25
Human heme oxygenase cDNA and induction of its mRNA by hemin. Eur J Biochem (1988) 2.16
The blepharophimosis, ptosis, and epicanthus inversus syndrome: delineation of two types. Am J Hum Genet (1983) 2.15
VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J Biol Chem (1997) 2.12
Anorectal malformations and Down syndrome. Am J Med Genet (1989) 1.97
Comparison of the clinical manifestations of cystic fibrosis in black and white patients. J Pediatr (1998) 1.97
Sporadic imprinting defects in Prader-Willi syndrome and Angelman syndrome: implications for imprint-switch models, genetic counseling, and prenatal diagnosis. Am J Hum Genet (1998) 1.87
Identification of common cystic fibrosis mutations in African-Americans with cystic fibrosis increases the detection rate to 75%. Am J Hum Genet (1997) 1.84
Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Ther (1996) 1.84
A PDZ-interacting domain in CFTR is an apical membrane polarization signal. J Clin Invest (1999) 1.73
Clustering of fibrillin (FBN1) missense mutations in Marfan syndrome patients at cysteine residues in EGF-like domains. Hum Mutat (1992) 1.71
Marfan phenotype variability in a family segregating a missense mutation in the epidermal growth factor-like motif of the fibrillin gene. J Clin Invest (1992) 1.68
Clinical and genetic studies of an autosomal dominant cone-rod dystrophy with features of Stargardt disease. Ophthalmic Genet (1999) 1.66
Whole-genome sequencing reveals complex mechanisms of intrinsic resistance to BRAF inhibition. Ann Oncol (2014) 1.64
Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population. JAMA (2000) 1.62
Molecular basis for the heterogeneity of human tyrosinase. Tohoku J Exp Med (1988) 1.58
A synonymous mutation in TCOF1 causes Treacher Collins syndrome due to mis-splicing of a constitutive exon. Am J Med Genet A (2009) 1.57
Housing status and health care service utilization among low-income persons with HIV/AIDS. J Gen Intern Med (2000) 1.56
Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis. J Clin Invest (1991) 1.56
Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros (2011) 1.54
Recurrent tetraamelia and pulmonary hypoplasia with multiple malformations in sibs. Am J Med Genet (1991) 1.52
Vascular endothelial growth factor and its receptors. Prog Growth Factor Res (1994) 1.50
Chalcone, acyl hydrazide, and related amides kill cultured Trypanosoma brucei brucei. Mol Med (2000) 1.49
ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations. Hum Mutat (2001) 1.45
Trampoline use as physiotherapy for cystic fibrosis patients. Pediatr Pulmonol (2005) 1.42
Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13. Nat Genet (1999) 1.41
Necrotising enterocolitis in the very low birthweight infant: expressed breast milk feeding compared with parenteral feeding. Arch Dis Child (1982) 1.41
Outcomes among tuberculosis patients with isoniazid resistance in Georgia, 2007-2009. Int J Tuberc Lung Dis (2012) 1.40
What is the role of tests of lung function in the management of infants with lung disease? Pediatr Pulmonol (2003) 1.40
Variable deletion of exon 9 coding sequences in cystic fibrosis transmembrane conductance regulator gene mRNA transcripts in normal bronchial epithelium. EMBO J (1991) 1.40
Pneumopericardium during continuous positive airway pressure in respiratory distress syndrome. Crit Care Med (1984) 1.38
Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Am J Hum Genet (1996) 1.38
A practical guide to Papanicolaou smear rescreens: how many slides must be reevaluated to make a statistically valid assessment of screening performance? Cancer (1998) 1.38
Adenosine, methacholine, and exercise challenges in children with asthma or paediatric chronic obstructive pulmonary disease. Thorax (1995) 1.37
A pilot study of the effect of gentamicin on nasal potential difference measurements in cystic fibrosis patients carrying stop mutations. Am J Respir Crit Care Med (2000) 1.37
The PDZ-interacting domain of cystic fibrosis transmembrane conductance regulator is required for functional expression in the apical plasma membrane. J Biol Chem (2000) 1.36
Both CFTR and outwardly rectifying chloride channels contribute to cAMP-stimulated whole cell chloride currents. Am J Physiol (1994) 1.35
Both the wild type and a functional isoform of CFTR are expressed in kidney. Am J Physiol (1996) 1.27
Genotype-phenotype relationships in cystic fibrosis. Med Clin North Am (2000) 1.26
Macromolecular organization of human centromeric regions reveals high-frequency, polymorphic macro DNA repeats. Proc Natl Acad Sci U S A (1989) 1.25
Consanguinity in a population sample of Israeli Muslim Arabs, Christian Arabs and Druze. Ann Hum Biol (2002) 1.23
Arginine for glycine substitution in the triple-helical domain of the products of one alpha 2(I) collagen allele (COL1A2) produces the osteogenesis imperfecta type IV phenotype. J Biol Chem (1988) 1.22
Treatment outcome of multi-drug resistant tuberculosis in the United Kingdom: retrospective-prospective cohort study from 2004 to 2007. Euro Surveill (2013) 1.21
Pericentric inversions of chromosome 9 in two families. Cytogenetics (1972) 1.19
CFTR nonsense mutations G542X and W1282X associated with severe reduction of CFTR mRNA in nasal epithelial cells. Hum Mol Genet (1992) 1.19
Analysis of ClC-2 channels as an alternative pathway for chloride conduction in cystic fibrosis airway cells. Proc Natl Acad Sci U S A (1998) 1.19
The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer. Am J Hum Genet (1999) 1.19
Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms. J Biol Chem (1995) 1.18
Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells. J Biol Chem (1996) 1.18
Low paternal dietary folate alters the mouse sperm epigenome and is associated with negative pregnancy outcomes. Nat Commun (2013) 1.18
Analysis of four diverse population groups indicates that a subset of cystic fibrosis mutations occur in common among Caucasians. Am J Hum Genet (1992) 1.17
Discrimination between recurrent mutation and identity by descent: application to point mutations in exon 11 of the cystic fibrosis (CFTR) gene. Hum Genet (1991) 1.16
Sib risk of neural tube defect: is prenatal diagnosis indicated in pregnancies following the birth of a hydrocephalic child? J Med Genet (1979) 1.16
Genetic markers in migrants to Israel. Isr J Med Sci (1971) 1.15
Effect of dexmedetomidine on propofol requirements in healthy subjects. J Pharm Sci (2001) 1.14
A single amino acid in gamma-aminobutyric acid rho 1 receptors affects competitive and noncompetitive components of picrotoxin inhibition. Proc Natl Acad Sci U S A (1995) 1.14
Clinical, physiologic, and psychologic comparison of treatment by cromolyn or theophylline in childhood asthma. J Allergy Clin Immunol (1985) 1.14
A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis. Hum Mol Genet (1998) 1.14
Influence of cardiac output on dexmedetomidine pharmacokinetics. J Pharm Sci (2000) 1.13
Two cystic fibrosis transmembrane conductance regulator mutations have different effects on both pulmonary phenotype and regulation of outwardly rectified chloride currents. Proc Natl Acad Sci U S A (1995) 1.13
Assessing spatiotemporal patterns of multidrug-resistant and drug-sensitive tuberculosis in a South American setting. Epidemiol Infect (2010) 1.13
A novel gamma-aminobutyric acid receptor subunit (rho 2) cloned from human retina forms bicuculline-insensitive homooligomeric receptors in Xenopus oocytes. J Neurosci (1994) 1.13
Data needs for evidence-based decisions: a tuberculosis modeler's 'wish list'. Int J Tuberc Lung Dis (2013) 1.12
The ATC (ataxia-telangiectasia complementation group C) locus localizes to 11q22-q23. Genomics (1991) 1.11
Exercise but not methacholine differentiates asthma from chronic lung disease in children. Thorax (1991) 1.11
Evolution of a genetic disease in an ethnic isolate: beta-thalassemia in the Jews of Kurdistan. Proc Natl Acad Sci U S A (1991) 1.11
A single histidine residue is essential for zinc inhibition of GABA rho 1 receptors. J Neurosci (1995) 1.10
A study of seroprevalence of HIV-1 and HIV-2 in six provinces of People's Republic of Angola: clues to the spread of HIV infection. J Acquir Immune Defic Syndr (1990) 1.10
Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants. Cancer Metastasis Rev (1996) 1.10
Confirmation and further regional assignment of aminoacylase 1 (acy-1) on human chromosome 3 using a simplified detection method. Ann Hum Genet (1980) 1.10
Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors. J Biol Chem (1994) 1.10
Vascular endothelial growth factor receptor-1 and neuropilin-2 form complexes. J Biol Chem (2001) 1.09
Comparison of budesonide and beclomethasone dipropionate for treatment of asthma. Arch Dis Child (1987) 1.08
Volume of procedures at transplantation centers and mortality after liver transplantation. N Engl J Med (2000) 1.08
Bronchial provocation tests in young children using tracheal auscultation. J Pediatr (1988) 1.08
Alternate translation initiation codons can create functional forms of cystic fibrosis transmembrane conductance regulator. J Biol Chem (1995) 1.08
HLA-DRw4 in pemphigus vulgaris patients in Israel. Tissue Antigens (1980) 1.08
Cost-benefit analysis of a national screening programme for cystic fibrosis in an Israeli population. Health Econ (1994) 1.08
Histocompatibility determinants in Israeli Jewish patients with coeliac disease: population and family study. Tissue Antigens (1981) 1.08
Cloning of a putative human voltage-gated chloride channel (CIC-2) cDNA widely expressed in human tissues. Hum Mol Genet (1995) 1.08
Accurate DNA-based diagnostic and carrier testing for X-linked adrenoleukodystrophy. Mol Genet Metab (1999) 1.07
Effect of vascular endothelial growth factor on hepatic regenerative activity following partial hepatectomy in rats. J Hepatol (1999) 1.07
CFTR protein expression in primary and cultured epithelia. Proc Natl Acad Sci U S A (1992) 1.07